DOCSLIB.ORG

Aldolase a Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion Through Promoting Glycolysis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Aldolase a Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion Through Promoting Glycolysis Int. J. Biol. Sci. 2021, Vol. 17 1782 Ivyspring International Publisher International Journal of Biological Sciences 2021; 17(7): 1782-1794. doi: 10.7150/ijbs.59068 Research Paper Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis Xiang Li1,2*, Chang Yu2*, Yichun Luo2*, Jiacheng Lin2, Fang Wang2, Xuehua Sun2, Yueqiu Gao2, Weifeng Tan1, Qiang Xia1, Xiaoni Kong2 1. Department of Hepatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. 2. Central Laboratory, Department of Liver Diseases, ShuGuang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Shanghai, China. * These authors contributed equally to this work. Corresponding authors: Xiaoni Kong, PhD, Central Laboratory, Department of Liver Diseases, ShuGuang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine,528 Zhangheng Road, Shanghai, China, 201203. Telephone: +86 21 20256838. E-mail: [email protected]; Or Qiang Xia, MD, PhD, E-mail: [email protected]; Or Weifeng Tan, MD, PhD, E-mail: [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2021.02.05; Accepted: 2021.04.05; Published: 2021.04.23 Abstract Energy metabolism reprogramming has been implicated in tumorigenesis and development. Key metabolism enzyme Aldolase A (ALDOA) has been shown to be highly expressed and involved in various kinds of cancers including hepatocellular carcinoma. In this study, we found that ALDOA was highly expressed in clinical intrahepatic cholangiocarcinoma (ICC) tissues, and its high expression was negatively correlated with overall survival (OS) and recurrence-free survival (RFS) in ICC patients. Knockdown of ALDOA expression significantly inhibited the proliferation and migration of ICC both in vitro and in vivo, while highly-expressed ALDOA in ICC cells promoted the proliferation and migration of ICC cells. By applying ALDOA inhibitor and metabolic mass spectrometry tests, we demonstrated that ALDOA modulated the biological characteristics and metabolic level of ICC cells depending on its enzymatic activity. In summary, ALDOA promotes ICC proliferation and migration by enhancing ICC cells glycolysis. Blocking enzymatic activity of ALDOA provides a strategy to inhibit ICC. Key words: Intrahepatic Cholangiocarcinoma, Aldolase A, Metabolism Reprogram, Enzymatic Activity, Glycolysis. Introduction Primary liver cancer is one of the most common many studies on the pathogenesis of intrahepatic malignancies of the digestive system. According to its cholangiocarcinoma, but no clear pathogenesis or pathological type, primary liver cancer can be divided effective treatment has been proposed. into hepatocellular carcinoma (HCC) and intrahepatic Having an abnormal metabolic level is one of the cholangiocarcinoma (ICC) [1]. ICC is a kind of main characteristics of tumor cells [4, 5]. As early as in malignant tumor that arises from the epithelial cells of the 1920s, Otto Warburg proposed that malignant segmental or proximal branches of the bile duct. The tumors mainly generate energy through glycolysis incidence rate of ICC accounts for 15% of all primary even in the presence of oxygen recombination rather liver malignancies, and it is the second most common than tricarboxylic acid cycling or oxidative liver cancer after HCC [2]. Although the incidence of phosphorylation. This phenomenon is also known as ICC is less than HCC, the degree of malignancy is the Warburg effect [6]. Currently, metabolic higher, the treatment tolerance is higher, and the abnormality, chiefly the Warburg effect, is thought to prognosis is poorer [3]. Therefore, ICC is a difficult play an important role in oncogenesis and tumor clinical problem that needs to be solved. There are progression in a variety of tumors [7]. Many glycolytic http://www.ijbs.com Int. J. Biol. Sci. 2021, Vol. 17 1783 enzymes such as PKM2 and HK have been proved to that were approved by the ethical review committee influence tumor progression by participating in the of the World Health Organization’s Collaborating regulation of tumor signal transduction [8], acting as a Center for Research in Human Production phospho-tyrosine-binding protein [9], or influencing (authorized by Shanghai Municipal Government). protein-protein interaction (PPI) of tumor cells as a The cholangiocarcinoma cell line RBE, HuCCT1 and coactivator [10]. FRH-0201 were purchased from the Cell Bank of the Aldolase A (ALDOA) is a member of the Chinese Academy of Sciences (Shanghai, China). aldolase family, mainly involved in the glycolysis pathway, catalyzing the reversible conversion of Cell culture β-D-fructose-1,6-bisphosphate to D-glyceraldehyde The ICC cell lines were cultured in RPMI 1640 3-phosphate and dihydroxyacetone phosphate [11]. medium (Gibco, C11875500CP) plus 10% (v/v) FBS Although the function of ALDOA in tumor (Gibco, 10099141C) plus Penicillin 100 U/mL and progression has been intensively studied, the role and Streptomycin 100μg/mL (Gibco, 15140122) at 37°C mechanism of ALDOA in liver cancer, especially in and 5% CO2. ICC, has not been studied yet. Through statistical RNA extraction, cDNA synthesis and qPCR analysis of clinical TCGA and GEO databases, we found that in liver tumors (including HCC and ICC Total RNA was extracted by total RNA rapid samples), the expression level of ALDOA was extraction kit (Bioteke Corporation, RP4002). A total significantly higher than that of adjacent cancer or of 500 ng RNA was reverse-transcribed using HiScript normal liver, and the expression of ALDOA was II Q RT SuperMix for the qPCR kit (Vazyme, R222-01). significantly and negatively related to the poor The cDNA was diluted (1:10) for qPCR using ChamQ prognosis of patients (Supplementary Figure 1), SYBR qPCR Master Mix (Vazyme, Q311-02) with suggesting that ALDOA might play an important gene-specific primers. Results were normalized by function in liver cancer. β-actin control. The primer sequences are as follows: In this study, we validated the expression levels ALDOA-Forward: 5’-GCTGTCACTGGGATCACC of ALDOA in clinical ICC samples and revealed a TTC-3’, ALDOA-Reverse: 5’-GCTCGGAGTGTA significant correlation between ALDOA expression CTTTCCTTGA-3’; β-actin Forward: 5’-ctccatcctggc and the survival rates of patients. Knockdown of ctcgctgt-3’, β-actin Reverse: 5’-gctgtcaccttcaccgttcc-3’. ALDOA significantly inhibited the proliferation and Protein extraction and Western blot migration of ICC cells, while exogenously-induced Cells or tumor tissues were lysed on ice with overexpression of ALDOA enhanced the proliferation RIPA (Thermo Scientific, 89900) containing protease of tumor cells. By using an inhibitor (Itaconate) to inhibitor (MCE, HY-K0010) for 30 mins. After repress the enzymatic activity of ALDOA, we found centrifugation for 10 mins at 12000 rpm, the that the tumor proliferation and invasion were supernatants were transferred to new EP tubes. The suppressed, suggesting that ALDOA promotes ICC protein samples were quantified by the BCA method. cell proliferation through its enzymatic activity. Then samples were denatured at 100 ℃ for 10 mins. Further, by testing the glycolytic function with Protein extracts were resolved on 12% SDS-PAGE seahorse and detecting downstream metabolites of gels, transferred to nitrocellulose membranes (0.45 the glycolysis pathway by mass spectrometry, we mm) after electrophoresis, and immunoblotted with found that the knockdown of ALDOA expression in special primary antibodies. Images were developed tumor cells leads to a lower level of glycolytic with ECL (GE Health Care, USA). The ALDOA products compared to that of control cells. All these antibody (11217-1-AP) was purchased from findings may help to better understand the Proteintech. The β-actin antibody with HRP (A3854) pathogenesis of ICC and provide a new target for ICC and the anti-flag M2 antibody (F1804) were purchased treatment. from Sigma. Materials and methods Tissue microarrays and immunohistochemical Clinical specimens and cell lines staining The human tumor and paired para-tumor tissues The ICC tissue microarrays contain 52 matched and ICC specimens of the validation cohort were pairs of specimens. Strict pathological diagnoses and obtained from ICC patients undergoing hepatectomy post-operative follow-ups were performed for all at Renji Hospital affiliated to Shanghai Jiaotong patients. IHC staining was performed to detect the University School of Medicine. Patient samples were expression of ALDOA. Sections were scored as obtained following informed consent and protocols positive if tumor cells showed a staining reaction in the cytoplasm and/or the nucleus. A quantitative http://www.ijbs.com Int. J. Biol. Sci. 2021, Vol. 17 1784 score was given by estimating the percentages of reagents were added and cells were incubated at 37°C positive cells: 0, (0–5%); 1, (5%–25%); 2, (25%–50%); 3, for 2 hrs before being measured at the wavelength of (50%–75%); and 4, (75%–100%). The intensity of 450 nm by the microplate reader. All experiments positive staining was given scores as negative (0), were performed independently at least 3 times. pallide-flavens grains (1), buffy grains (2), and brown-black grains (3) respectively. Finally, total Wound healing assay scores (0–7) for each sample were determined by the Cells were cultured in 6-well
Load more

Recommended publications
  • Early Modifications of Gene Expression Induced in Liver by Azo-Dye Diet
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 206, number 2 FEBS 4070 October 1986 Early modifications of gene expression induced in liver by azo-dye diet EugCnia Lamas, Fabien Schweighoffer and Axe1 Kahn Unit& de Recherches en GP&tique et Pathologie Mol&ulaires, INSERM U 129, CHU COCHIN, 24, Rue du Faubourg Saint Jacques, 75674 Paris Cedex 14, France Received 5 August 1986 The expression and regulation of the phosphoenolpyruvate carboxykinase gene were not grossly modified by feeding rats a 3’-methyl-4-(dimethylamino)azobenzene-containing diet despite maximum expression of the L-type pyruvate kinase gene being dramatically reduced as early as the 24th hour of the carcinogenic diet. Inhibition of aldolase B mRNA synthesis occurred more slowly, being maximum at the 3rd day. After stopping administration of the carcinogen, a very rapid, but transient increase of the L-type pyruvate kinase mRNA was observed at the 24th hour, whereas aldolase B mRNA increased only slowly. The amount of aldolase A mRNA fell quickly after termination of carcinogen administration, levels being normal at the 2nd-3rd day. At this time, the histological structure of the liver was indistinguishable from that of animals still receiving the azo-dye diet. It appears, therefore, that in the rat both administration and withdrawal of the azo-dye carcinogen induce rapid modifications of the expression of some genes, before any cellular modification is distinguishable. Azo-dye diet mRNA Hepatocarcinogenesis Phosphoenolpyruvate carboxykinase Aldolase Pyruvate kinase 1. INTRODUCTION some genes. Such a possibility is of theoretical im- portance because it could constitute the basis for The azo-dye 3’-methyl-4-(dimethylamino)azo- the carcinogenic action of the dye.
    [Show full text]
  • Exploring the Non-Canonical Functions of Metabolic Enzymes Peiwei Huangyang1,2 and M
    © 2018. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2018) 11, dmm033365. doi:10.1242/dmm.033365 REVIEW SPECIAL COLLECTION: CANCER METABOLISM Hidden features: exploring the non-canonical functions of metabolic enzymes Peiwei Huangyang1,2 and M. Celeste Simon1,3,* ABSTRACT A key finding from studies of metabolic enzymes is the existence The study of cellular metabolism has been rigorously revisited over the of mechanistic links between their nuclear localization and the past decade, especially in the field of cancer research, revealing new regulation of transcription. By modulating gene expression, insights that expand our understanding of malignancy. Among these metabolic enzymes themselves facilitate adaptation to rapidly insights isthe discovery that various metabolic enzymes have surprising changing environments. Furthermore, they can directly shape a ’ activities outside of their established metabolic roles, including in cell s epigenetic landscape (Kaelin and McKnight, 2013). the regulation of gene expression, DNA damage repair, cell cycle Strikingly, several metabolic enzymes exert completely distinct progression and apoptosis. Many of these newly identified functions are functions in different cellular compartments. Nuclear fructose activated in response to growth factor signaling, nutrient and oxygen bisphosphate aldolase, for example, directly interacts with RNA ́ availability, and external stress. As such, multifaceted enzymes directly polymerase III to control transcription (Ciesla et al., 2014),
    [Show full text]
  • Datasheet: VPA00226
    Datasheet: VPA00226 Description: RABBIT ANTI ALDOA Specificity: ALDOA Format: Purified Product Type: PrecisionAb™ Polyclonal Isotype: Polyclonal IgG Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Species Cross Reacts with: Mouse, Rat Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation Rabbit Ig fraction prepared by ammonium sulphate precipitation Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN3) Stabilisers Immunogen KLH conjugated synthetic peptide between 66-95 amino acids from the N-terminal region of human ALDOA External Database UniProt: Links P04075 Related reagents Entrez Gene: 226 ALDOA Related reagents Page 1 of 2 Synonyms ALDA Specificity Rabbit anti Human ALDOA antibody recognizes fructose-bisphosphate aldolase A, also known as epididymis secretory sperm binding protein Li 87p, fructose-1,6-bisphosphate triosephosphate-lyase, lung cancer antigen NY-LU-1 and muscle-type aldolase. Encoded by the ALDOA gene, fructose-bisphosphate aldolase A is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate.
    [Show full text]
  • Effect of STAT3 Inhibition on the Metabolic Switch in a Highly STAT3-Activated Lymphoma Cell Line
    CANCER GENOMICS & PROTEOMICS 12 : 133-142 (2015) Effect of STAT3 Inhibition on the Metabolic Switch in a Highly STAT3-activated Lymphoma Cell Line YASUTO AKIYAMA 1* , AKIRA IIZUKA 1* , AKIKO KUME 1, MASARU KOMIYAMA 1, KENICHI URAKAMI 2, TADASHI ASHIZAWA 1, HARUO MIYATA 1, MAHO OMIYA 1, MASATOSHI KUSUHARA 3 and KEN YAMAGUCHI 4 1Immunotherapy Division, 2Cancer Diagnostics Division, 3Regional Resources Division, Shizuoka Cancer Center Research Institute, Sunto-gun, Shizuoka, Japan; 4Office of the President, Shizuoka Cancer Center Hospital, Sunto-gun, Shizuoka, Japan Abstract. Background: Signal transducer and activator of enzymes including fructose-bisphosphate aldolase A transcription (STAT)3 is involved in a metabolic shift in (ALDOA) as a metabolic marker candidate for STAT3- cancer cells, the Warburg effect through its pro-oncogenic targeting therapy using STAT3-specific shRNA gene activity. To develop efficient STAT3 inhibitors against cancer transduction. In particular, latexin expression was up- cells, novel proteomic and metabolic target molecules need regulated in four STAT3-activated cancer cell lines including to be explored using multi-omics approaches in the context of SCC-3 transduced with STAT3-specific shRNA. The up- STAT3 gene inhibition-mediated tumor growth suppression. regulation of latexin was identified in SCC-3 tumors Materials and Methods: We found that short hairpin transplanted to nude mice after treatment with STAT3 (sh)RNA-mediated STAT3 inhibition suppressed tumor inhibitor. Conclusion: Our results suggest that STAT3 growth in a highly STAT3-activated lymphoma cell line, inactivation reverses the glycolytic shift by down-regulating SCC-3 cells, and we investigated the effect of STAT3 key enzymes and that it induces up-regulation of latexin as a inhibition on metabolic switching using 2-dimensional tumor-suppressor molecule, which partially results in cancer differential gel electrophoresis and capillary electrophoresis- cell apoptosis and tumor growth suppression.
    [Show full text]
  • Brownian Dynamics Simulations of Aldolase Binding Glyceraldehyde 3- Phosphate Dehydrogenase and the Possibility of Substrate Channeling
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biophysical Journal Volume 80 June 2001 2527–2535 2527 Brownian Dynamics Simulations of Aldolase Binding Glyceraldehyde 3- Phosphate Dehydrogenase and the Possibility of Substrate Channeling Igor V. Ouporov,* Harvey R. Knull,† Amanda Huber,* and Kathryn A. Thomasson* *Department of Chemistry, University of North Dakota; and †Department of Biochemistry and Molecular Biology, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, USA ABSTRACT Brownian dynamics (BD) simulations test for channeling of the substrate, glyceraldehyde 3-phosphate (GAP), as it passes between the enzymes fructose-1,6-bisphosphate aldolase (aldolase) and glyceraldehyde 3-phosphate dehydro- genase (GAPDH). First, BD simulations determined the favorable complexes between aldolase and GAPDH; two adjacent subunits of GAPDH form salt bridges with two subunits of aldolase. These intermolecular contacts provide a strong electrostatic interaction between the enzymes. Second, BD simulates GAP moving out of the active site of the A or D aldolase subunit and entering any of the four active sites of GAPDH. The efficiency of transfer is determined as the relative number of BD trajectories that reached any active site of GAPDH. The distribution functions of the transfer time were calculated based on the duration of successful trajectories. BD simulations of the GAP binding from solution to aldolase/GAPDH complex were compared to the channeling simulations. The efficiency of transfer of GAP within an aldolase/GAPDH complex was 2 to 3% compared to 1.3% when GAP was binding to GAPDH from solution.
    [Show full text]
  • Therapeutic Targeting of Aldolase a Interactions Inhibits Lung Cancer Metastasis
    Author Manuscript Published OnlineFirst on July 29, 2019; DOI: 10.1158/0008-5472.CAN-18-4080 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis 2 and Prolongs Survival 3 4 Yu-Chan Chang 1, Jean Chiou1, Yi-Fang Yang2, Chia-Yi Su1, Yuan-Feng Lin3, Chia-Ning Yang4, 5 Pei-Jung Lu5, Ming-Shyan Huang 6, Chih-Jen Yang7* and Michael Hsiao 1,8* 6 7 1. Genomics Research Center, Academia Sinica, Taipei, Taiwan. 8 2. Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung Medical 9 University, Kaohsiung, Taiwan. 10 3. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, 11 Taiwan. 12 4. Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Taiwan. 13 5. Institute of Clinical Medicine, Medical College, National Cheng Kung University, Tainan, Taiwan 14 6. Department of Internal Medicine, E-DA Cancer Hospital, School of Medicine, I-Shou University, 15 Kaohsiung, Taiwan. 16 7. Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical 17 University, Kaohsiung, Taiwan. 18 8. Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung, 19 Taiwan. 20 21 *To whom correspondence should be addressed: 22 Dr. Michael Hsiao, Genomics Research Center, Academia Sinica, 128 Academia Rd., Sec. 2, 23 Nankang-Dist., Taipei, Taiwan. Tel: +886-2-2787-1243, Fax: +886-2-2789-9931, E-mail: 24 [email protected] 25 Or to 1 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2019 American Association for Cancer Research.
    [Show full text]
  • Orlistat, a Novel Potent Antitumor Agent for Ovarian Cancer: Proteomic Analysis of Ovarian Cancer Cells Treated with Orlistat
    INTERNATIONAL JOURNAL OF ONCOLOGY 41: 523-532, 2012 Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat HUI-QIONG HUANG1*, JING TANG1*, SHENG-TAO ZHOU1, TAO YI1, HONG-LING PENG1, GUO-BO SHEN2, NA XIE2, KAI HUANG2, TAO YANG2, JIN-HUA WU2, CAN-HUA HUANG2, YU-QUAN WEI2 and XIA ZHAO1,2 1Gynecological Oncology of Biotherapy Laboratory, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, Sichuan; 2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China Received February 9, 2012; Accepted March 19, 2012 DOI: 10.3892/ijo.2012.1465 Abstract. Orlistat is an orally administered anti-obesity drug larly PKM2. These changes confirmed our hypothesis that that has shown significant antitumor activity in a variety of Orlistat is a potential inhibitor of ovarian cancer and can be tumor cells. To identify the proteins involved in its antitumor used as a novel adjuvant antitumor agent. activity, we employed a proteomic approach to reveal protein expression changes in the human ovarian cancer cell line Introduction SKOV3, following Orlistat treatment. Protein expression profiles were analyzed by 2-dimensional polyacrylamide In the 1920s, the Nobel Prize winner Otto Warburg observed gel electrophoresis (2-DE) and protein identification was a marked increase in glycolysis and enhanced lactate produc- performed on a MALDI-Q-TOF MS/MS instrument. More tion in tumor cells even when maintained in conditions of high than 110 differentially expressed proteins were visualized oxygen tension (termed Warburg effect), leading to widespread by 2-DE and Coomassie brilliant blue staining.
    [Show full text]
  • A Review of Isozymes in Cancer1
    Cancer Research VOLUME31 NOVEMBER 1971 NUMBER11 [CANCER RESEARCH 31, 1523-1542, November 1971] A Review of Isozymes in Cancer1 Wayne E. Criss Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32601 TABLE OF CONTENTS postulated role for that particular isozymic system in cellular metabolism. Summary 1523 Introduction 1523 Normal enzyme differentiation 1523 INTRODUCTION Tumor enzyme differentiation 1524 Isozymes 1524 Normal Enzyme Differentiation DNA polymerase 1524 Enzyme differentiation is the process whereby, during the Hexokinase 1525 Fructose 1,6-diphosphatase 1525 development of an organ in an animal, the organ acquires the quantitative and qualitative adult enzyme patterns (122). Key Aldolase 1526 pathway enzymes in several metabolic processes have been Pyruvate kinase 1527 found to undergo enzymatic differentiation. The enzymes Láclatedehydrogenase 1527 Isocitrate dehydrogenase 1527 involved in nitrogen metabolism, and also in urea cycle Malate dehydrogenase 1528 metabolism (180), are tyrosine aminotransferase (123, 151, Glycerol phosphate dehydrogenase 1529 330, 410), tryptophan pyrrolase (261), serine dehydratase Glutaminase 1529 (123, 410), histidine ammonia lyase (11), and aspartate Aspartate aminotransferase 1530 aminotransferase (337, 388). The enzymes involved in nucleic Adenylate kinase 1531 acid metabolism are DNA polymerase (156, 277) and RNase (52). In glycolysis the enzymes are hexokinase-glucokinase Carbamyl phosphate synthetase 1531 Lactose synthetase 1533 (98, 389), galactokinase 30, aldolase (267, 315), pyruvate Discussion 1533 kinase (73, 386), and lactate dehydrogenase (67, 69). In References 1533 mitochondrial oxidation they are NADH oxidase, succinic oxidase, a-glycero-P oxidase, ATPase, cytochrome oxidase, and flavin content (84, 296). In glycogen metabolism the SUMMARY enzymes involved are UDPG pyrophosphorylase and UDPG glucosyltransferase (19).
    [Show full text]
  • Metabolic Enzyme Expression Highlights a Key Role for MTHFD2 and the Mitochondrial Folate Pathway in Cancer
    ARTICLE Received 1 Nov 2013 | Accepted 17 Dec 2013 | Published 23 Jan 2014 DOI: 10.1038/ncomms4128 Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer Roland Nilsson1,2,*, Mohit Jain3,4,5,6,*,w, Nikhil Madhusudhan3,4,5, Nina Gustafsson Sheppard1,2, Laura Strittmatter3,4,5, Caroline Kampf7, Jenny Huang8, Anna Asplund7 & Vamsi K. Mootha3,4,5 Metabolic remodeling is now widely regarded as a hallmark of cancer, but it is not clear whether individual metabolic strategies are frequently exploited by many tumours. Here we compare messenger RNA profiles of 1,454 metabolic enzymes across 1,981 tumours spanning 19 cancer types to identify enzymes that are consistently differentially expressed. Our meta- analysis recovers established targets of some of the most widely used chemotherapeutics, including dihydrofolate reductase, thymidylate synthase and ribonucleotide reductase, while also spotlighting new enzymes, such as the mitochondrial proline biosynthetic enzyme PYCR1. The highest scoring pathway is mitochondrial one-carbon metabolism and is centred on MTHFD2. MTHFD2 RNA and protein are markedly elevated in many cancers and correlated with poor survival in breast cancer. MTHFD2 is expressed in the developing embryo, but is absent in most healthy adult tissues, even those that are proliferating. Our study highlights the importance of mitochondrial compartmentalization of one-carbon metabolism in cancer and raises important therapeutic hypotheses. 1 Unit of Computational Medicine, Department of Medicine, Karolinska Institutet, 17176 Stockholm, Sweden. 2 Center for Molecular Medicine, Karolinska Institutet, 17176 Stockholm, Sweden. 3 Broad Institute, Cambridge, Massachusetts 02142, USA. 4 Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
    [Show full text]
  • (ALDOA) Associates with Cell Cycle-Related Genes in Patients With
    Zhang et al. BioData Mining (2017) 10:6 DOI 10.1186/s13040-016-0122-4 RESEARCH Open Access Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors Fan Zhang1, Jie-Diao Lin1, Xiao-Yu Zuo2, Yi-Xuan Zhuang1, Chao-Qun Hong1, Guo-Jun Zhang1, Xiao-Jiang Cui3 and Yu-Kun Cui1* * Correspondence: [email protected] Abstract 1Guangdong Provincial Key Laboratory for Breast Cancer Background: Aldolase A (ALDOA) is one of the glycolytic enzymes primarily found in Diagnosis and Treatment, Cancer the developing embryo and adult muscle. Recently, a new role of ALDOA in several Hospital of Shantou University cancers has been proposed. However, the underlying mechanism remains obscure and Medical College, Shantou 515041, China inconsistent. In this study, we tried to investigate ALDOA-associated (AA) genes using Full list of author information is available microarray datasets to help elucidating the role of ALDOA in cancer. available at the end of the article Results: In the dataset of patients with non-small-cell lung cancer (NSCLC, E-GEOD- 19188), 3448 differentially expressed genes (DEGs) including ALDOA were identified, in which 710 AA genes were found to be positively associated with ALDOA. Then according to correlation coefficients between each pair of AA genes, ALDOA-associated gene co-expression network (GCN) was constructed including 182 nodes and 1619 edges. 11 clusters out of GCN were detected by ClusterOne plugin in Cytoscape, and only3ofthemhavemorethanthreenodes.Thesethreeclusterswerefunctionally enriched. A great number of genes (43/79, 54.4%) in the biggest cluster (Cluster 1) primarily involved in biological process like cell cycle process (Pa = 6.76E-26), mitotic cell cycle (Pa = 4.09E-19), DNA repair (Pa = 1.13E-04), M phase of meiotic cell cycle (Pa = 0.006), positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle (Pa =0.014).
    [Show full text]
  • How Do Glycolytic Enzymes Favour Cancer Cell Proliferation by Nonmetabolic Functions?
    Oncogene (2015) 34, 3751–3759 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc REVIEW How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? H Lincet1,2,3 and P Icard1,4 Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-3-phosphate dehydrogenase activate survival pathways (Akt and so on); phosphofructokinase 1 and triose phosphate isomerase participate in cell cycle activation; aldolase promotes epithelial mesenchymal transition; PKM2 enhances various nuclear effects such as transcription, stabilisation and so on. This review outlines the multiple non-glycolytic roles of glycolytic enzymes, which are essential for promoting cancer cells' survival, proliferation, chemoresistance and dissemination. Oncogene (2015) 34, 3751–3759; doi:10.1038/onc.2014.320; published online 29 September 2014 INTRODUCTION implications in many other functions, such as apoptosis, In normal tissue, the vast majority of nonproliferating differen- detoxification, cell cycle control, signalling pathways and so on. tiated cells use oxidative phosphorylation (OXPHOS) for ATP production. These cells metabolise glucose to pyruvate through Hexokinases glycolysis, then oxidise this pyruvate through the tricarboxylic acid In the cytosol, glucose (or fructose) is phosphorylated by cycle, generating ATP through ATP synthase, the rate of the hexokinases (HK) (glucose kinase or fructose kinase) to glucose- production being coupled with proton transport and on oxygen 6-phosphate (G6P). HK catalye the first irreversible reaction of respiration.1 In contrast, rapidly proliferating tumour cells con- glycolysis.
    [Show full text]
  • Transcriptional Control of Genes That Regulate Glycolysis and Gluconeogenesis in Adult Liver Frederic P
    Biochem. J. (1994) 303, 1-14 (Printed in Great Britain) 1 REVIEW ARTICLE Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver Frederic P. LEMAIGRE and Guy G. ROUSSEAU* Hormone and Metabolic Research Unit, University of Louvain Medical School and International Institute of Cellular and Molecular Pathology, 75 Avenue Hippocrate, B-1200 Brussels, Belgium INTRODUCTION listed in Table 1. The ubiquitous factors that control the genes discussed here are listed in Table 2. These genes code for Glycolysis is the metabolic pathway through which glucose is glucokinase, 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6- converted into pyruvate, with a net yield of 2 mol of ATP and bisphosphatase (FBPase-2), pyruvate kinase and phosphoenol- NADH per mol of glucose used. In liver, where the glycolytic pyruvate carboxykinase (PEPCK), namely enzymes that control flux is low except when glucose concentrations are high or key steps, and for aldolase and glyceraldehyde-3-phosphate during anoxia, the main function of glycolysis is to provide dehydrogenase (GAPDH), which are enzymes controlling re- substrates for anabolic processes. While glycolysis occurs in versible steps. every tissue, gluconeogenesis is specific for the liver, the kidney In the present paper, we will review the data pertaining to the and the small intestine. Gluconeogenesis supplies glucose to the transcriptional control of these genes in liver. We will describe body and provides a way to dispose of amino acids and lactate first the glycolytic enzymes and then the gluconeogenic enzyme produced by erythrocytes and during muscle contraction. It is PEPCK. Aldolase B and GAPDH are discussed with the also a means of disposal for glycerol produced during lipolysis.
    [Show full text]